Meddus Pharma

Meddus Pharma is a specialty pharmaceutical company focused on developing Value Added Medicines (VAMs) to address unmet needs in oncology, supportive care, and rare diseases. The company utilizes the 505(b)(2) and hybrid regulatory pathways to bring reformulated versions of established drugs to market with improved safety, efficacy, and patient convenience. Their pipeline includes proprietary oral liquid formulations and injectable therapies designed for specific patient populations, including pediatric and geriatric groups. Meddus aims to bridge the gap between standard generics and expensive new chemical entities by providing cost-effective, clinically superior alternatives. The company leverages strategic partnerships for manufacturing and distribution while maintaining internal expertise in formulation science and regulatory strategy.